Nanomedicine: Visions for the Future
24 - 25th February 2010
In the latest of its highly-successful series of conferences addressing the new field of nanomedicine and related medical technologies, the Institute of Nanotechnology, in partnership with NanoNed, is holding a unique event to highlight the latest developments in this innovative area.
The ‘Nanomedicine: Visions for the Future’ conference, taking place on 24th and 25th Febrary at the NH Carlton Amsterdam Hotel, Amsterdam, brings together some of the world’s leading researchers and companies in the fields of medical diagnostics, drug design and delivery, imaging and regenerative medicine to show how the application of nanoscience and nanotechnologies can contribute towards answering this multifaceted challenge.
Modern medicine is rapidly reaching a crossroads where greatly increased knowledge of how the human body and disease pathologies work at the molecular level is combining with the ability to manipulate materials at the nanoscale to provide much earlier and more accurate diagnoses, far less invasive procedures, targeting of smaller doses of more effective drugs to desired delivery sites and new paradigms of treatment where damaged tissues or even organs can be regenerated using the patient’s own cells.
New generations of highly-informed patients are also beginning to expect new treatments with a better prognosis to maintain healthy, active lifestyles into old age.
At the same time, healthcare services everywhere are under severe economic pressures to restrain costs in a demographically-ageing society where illnesses such as cardiovascular disease, cancer, diabetes, degenerative and neurological conditions are placing an ever-greater strain on resources. Companies also face greater challenges in a time of financial uncertainty in developing new products and medical technologies, based on a highly-convergent scientific approach, to address a range of, as yet, unmet clinical needs.
In this complex scenario, how can better treatments be delivered more effectively, and within budgetary constraints, to an ever-increasing patient base? These are some of the issues that will be addressed at this event. The Conference will be invaluable to all involved in meeting this challenge including medical researchers, industry, healthcare professionals, regulators, technology assessors and those involved in the delivery and financing of healthcare.
For more information please contact Carrie Smith at the Institute of Nanotechnology: +44(0)141 303 8444 or email: firstname.lastname@example.org
Source: Conference Homepage /...
Previous Story: A new approach to optimizing molecular self-organization
Next Story: Nanotechnology sparks energy storage on paper and cloth
The Institute of Nanotechnology puts significant effort into ensuring that the information provided on its news pages is accurate and up-to-date. However, we cannot guarantee absolute accuracy. Consequently, the Institute of Nanotechnology disclaims any and all responsibility for inaccuracy, omission or any kind of deficiency in relation to the news items and articles hosted herein.
- 04 March 2014NanoCelluComp presents final results at JEC Europe 2014
- 17 February 2014Researchers Hijack Cancer Migration Mechanism to “Move” Brain Tumours
- 12 February 2014Fingerprinting meningitis with lasers
- 06 February 2014European Innovation Convention 2014
- 30 January 2014NanoSafety Cluster Newsletter No.2 - Out Now
- View All